Safety and ARIA Results of the Oral Anti‐Amyloid Agent Valiltramiprosate from the Phase 3 APOLLOE4 Trial in APOE4/4 Homozygotes with Early ADPatrick Kesslak, Martin Tolar, David Watson et al.|Alzheimer s & Dementia|2025Cited by 0